Abstract
AbstractThis business is not a steady one where you are always making a reasonable rate of progress. You will have a group of compounds, things will be going well. All of a sudden, disaster and some are lost. The regulatory authority will find something that reasonable people think is okay, but they don't. It happens all the time.President, Pharmaceutical Company The pharmaceutical industry can be a frustrating workplace. The majority of compounds synthesized die in research. By the time a compound proves itself commercially viable, ten years may have elapsed with the company having invested anywhere from 30 to 100 million dollars. But great financial rewards exist for the company that creates a breakthrough drug.The men and women who work in the industry share common concerns about their careers and about staying motivated to run the long race with its circuitous road. In 1981, at the suggestion of Dr. Irene Chow of CIBA-GEIGY and Dr. Jerry Johnson of Syntex, I looked into the problem of stalled technica...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical Research Practices and Drug Regulatory Affairs
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
